MARSHALL WACE, LLP - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 58 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$105,792
+18.9%
25,492
+35.5%
0.00%
Q2 2022$89,000
-31.0%
18,808
-42.7%
0.00%
Q1 2022$129,000
-87.8%
32,825
-79.0%
0.00%
-100.0%
Q4 2021$1,056,000
-54.5%
156,2500.0%0.00%
-80.0%
Q3 2021$2,322,000156,2500.01%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders